Literature DB >> 12968817

Variations in patterns of care and outcomes after acute myocardial infarction for Medicare beneficiaries in fee-for-service and HMO settings.

Harold S Luft1.   

Abstract

OBJECTIVE: To assess revascularization and mortality after acute myocardial infarction (AMI) for all Medicare patients in fee-for-service (FFS) and health maintenance organization (HMO) settings in California. DATA SOURCES/STUDY
SETTING: Hospital discharge abstract and death certificate data linked with Medicare enrollment files for patients aged 65 and over with Medicare coverage (69,040) discharged from a California-licensed hospital in 1994-1996. STUDY
DESIGN: Risk-adjusted results were assessed for HMOs and FFS, as well as for FFS beneficiaries from areas served by each plan. DATA COLLECTION/EXTRACTION
METHODS: Risk models were based on all sampled patients. The HMO patients were aggregated into 17 pseudoplans: 5 individual plans, 4 large plans split geographically (10 observations), and 2 "pseudoplans" of small HMOs. Observed versus expected 30-day mortality rates, lengths-of-stay (LOS) during the index hospitalization and any transfers, revascularization (coronary artery bypass graft [CABG] surgery and/or percutaneous transluminal coronary angioplasty [PTCA]) during the index hospitalization or 30 days after admission, were calculated for each pseudoplan. PRINCIPAL
FINDINGS: Risk-adjusted death rate was slightly higher in FFS than in HMO settings (p < .01 with one risk adjustment model, n.s. with another). Three pseudoplans had significantly (p < .01) better than expected mortality rates. One pseudoplan was significantly worse (p < .05) with one risk adjustment model but not the other. The LOS and revascularization rates varied widely, but were not associated with outcomes. Plans with among the best results had the lowest LOS and revascularization rates. These pseudoplans were less likely to have their patients initially admitted to a hospital with revascularization capability, but the hospitals they used had higher CABG volumes. Even if CABG facilities were available during the index admission, in these plans with better than expected mortality rates, revascularization was often postponed or carried out elsewhere.
CONCLUSIONS: For Medicare patients having an AMI in the mid-1990s in California, risk-adjusted outcomes were no different, or slightly better on average, for those in HMOs than in FFS. Not all plans performed equally well, so understanding what leads to differences in quality is more important than simple comparisons of HMOs versus FFS.

Entities:  

Mesh:

Year:  2003        PMID: 12968817      PMCID: PMC1360933          DOI: 10.1111/1475-6773.00163

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  18 in total

1.  How does managed care do it?

Authors:  D M Cutler; M McClellan; J P Newhouse
Journal:  Rand J Econ       Date:  2000

Review 2.  HMO plan performance update: an analysis of the literature, 1997-2001.

Authors:  Robert H Miller; Harold S Luft
Journal:  Health Aff (Millwood)       Date:  2002 Jul-Aug       Impact factor: 6.301

3.  Selective referral to high-volume hospitals: estimating potentially avoidable deaths.

Authors:  R A Dudley; K L Johansen; R Brand; D J Rennie; A Milstein
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

4.  Does managed care lead to better or worse quality of care?

Authors:  R H Miller; H S Luft
Journal:  Health Aff (Millwood)       Date:  1997 Sep-Oct       Impact factor: 6.301

5.  Long-term MI outcomes at hospitals with or without on-site revascularization.

Authors:  D A Alter; C D Naylor; P C Austin; J V Tu
Journal:  JAMA       Date:  2001-04-25       Impact factor: 56.272

6.  Managed care plan performance since 1980. A literature analysis.

Authors:  R H Miller; H S Luft
Journal:  JAMA       Date:  1994-05-18       Impact factor: 56.272

7.  The relationship between managed care insurance and use of lower-mortality hospitals for CABG surgery.

Authors:  L C Erickson; D F Torchiana; E C Schneider; J W Newburger; E L Hannan
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

8.  Access and outcomes of elderly patients enrolled in managed care.

Authors:  D G Clement; S M Retchin; R S Brown; M H Stegall
Journal:  JAMA       Date:  1994-05-18       Impact factor: 56.272

9.  HMO vs fee-for-service care of older persons with acute myocardial infarction.

Authors:  D M Carlisle; A L Siu; E B Keeler; E A McGlynn; K L Kahn; L V Rubenstein; R H Brook
Journal:  Am J Public Health       Date:  1992-12       Impact factor: 9.308

10.  Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables.

Authors:  M McClellan; B J McNeil; J P Newhouse
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

View more
  6 in total

1.  Tribute to John M. Eisenberg.

Authors:  Ann Barry Flood; Harold S Luft
Journal:  Health Serv Res       Date:  2003-08       Impact factor: 3.402

2.  Change in health status and mortality as indicators of outcomes: comparison between the Medicare Advantage Program and the Veterans Health Administration.

Authors:  Alfredo J Selim; Lewis E Kazis; William Rogers; Shirley X Qian; James A Rothendler; Avron Spiro; Xinhua S Ren; Donald Miller; Bernardo J Selim; Benjamin G Fincke
Journal:  Qual Life Res       Date:  2007-05-25       Impact factor: 4.147

3.  Factors affecting use of resources for asthma patients.

Authors:  Bayram Sahin; Mehtap Tatar
Journal:  J Med Syst       Date:  2006-10       Impact factor: 4.460

4.  Do Medicare Advantage enrollees tend to be admitted to hospitals with better or worse outcomes compared with fee-for-service enrollees?

Authors:  Bernard Friedman; H Joanna Jiang
Journal:  Int J Health Care Finance Econ       Date:  2010-02-06

5.  Managing care? Medicare managed care and patient use of cardiologists.

Authors:  Marco D Huesch
Journal:  Health Serv Res       Date:  2009-12-30       Impact factor: 3.402

6.  Is technological change in medicine always worth it? The case of acute myocardial infarction.

Authors:  Jonathan S Skinner; Douglas O Staiger; Elliott S Fisher
Journal:  Health Aff (Millwood)       Date:  2006-02-07       Impact factor: 9.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.